We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORIC icon
76
Oric Pharmaceuticals
ORIC
$1.11B
$17.7M 0.59%
522,302
+197,720
+61% +$5.67M
SSB icon
77
SouthState Bank Corp
SSB
$9.99B
$17.5M 0.58%
+242,390
New +$15.9M
AIMC
78
DELISTED
Altra Industrial Motion Corp
AIMC
$17.5M 0.58%
+314,898
New +$15.5M
ECHO
79
DELISTED
Echo Global Logistics, Inc.
ECHO
$17.2M 0.57%
640,836
+5,345
+0.8% +$150K
ITGR icon
80
Integer Holdings
ITGR
$3.28B
$17M 0.56%
209,103
+5,749
+3% +$403K
FIZZ icon
81
National Beverage
FIZZ
$2.9B
$16.8M 0.56%
+395,382
New +$17M
COLL icon
82
Collegium Pharmaceutical
COLL
$1.16B
$16.7M 0.56%
835,642
+122,279
+17% +$2.39M
HELE icon
83
Helen of Troy
HELE
$658M
$16.5M 0.55%
74,438
+280
+0.4% +$57.7K
PING
84
DELISTED
Ping Identity Holding Corp.
PING
$16.1M 0.53%
560,658
+200
+0% +$5.54K
FOXF icon
85
Fox Factory Holding Corp
FOXF
$779M
$15.5M 0.51%
146,281
+14,555
+11% +$1.32M
PRKS icon
86
United Parks & Resorts
PRKS
$2.11B
$15.4M 0.51%
487,062
+40,822
+9% +$1.06M
CVET
87
DELISTED
Covetrus, Inc. Common Stock
CVET
$15M 0.5%
522,575
+380,473
+268% +$10.3M
RPAY icon
88
Repay Holdings
RPAY
$315M
$14.7M 0.49%
+539,053
New +$13.1M
VICR icon
89
Vicor
VICR
$10.8B
$14.4M 0.48%
155,836
-15,267
-9% -$1.28M
TECX
90
Tectonic Therapeutic
TECX
$615M
$14.1M 0.47%
84,101
+16,891
+25% +$3M
PLCE icon
91
Children's Place
PLCE
$58.9M
$13.9M 0.46%
276,749
-15,344
-5% -$558K
TMDX icon
92
Transmedics
TMDX
$2.52B
$13.4M 0.44%
672,880
+21,697
+3% +$321K
ACA icon
93
Arcosa
ACA
$7.11B
$12.9M 0.43%
234,532
+1,640
+0.7% +$83.7K
DRNA
94
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$12.9M 0.43%
584,342
+66,858
+13% +$1.47M
CRIS icon
95
Curis
CRIS
$8.91M
$12.9M 0.43%
+3,927
New +$4.72M
COHU icon
96
Cohu
COHU
$2.45B
$12.6M 0.42%
+331,227
New +$9.04M
GLUU
97
DELISTED
Glu Mobile Inc.
GLUU
$12.6M 0.42%
1,403,141
-1,725,366
-55% -$14.9M
CHUY
98
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$12.6M 0.42%
474,886
+1,500
+0.3% +$35.6K
APLT
99
DELISTED
Applied Therapeutics
APLT
$11.4M 0.38%
515,724
+10,649
+2% +$222K
CTLP
100
DELISTED
Cantaloupe
CTLP
$11.3M 0.38%
1,078,842
-9,156
-0.8% -$89.5K
2 3
4
5 6

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.